The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
Àrees Recerca
HEALTH SERVICES RESEARCH
GAVINA
GAVINA
Grup d'avaluació d'intervencions en atenció primària (GAVINA)
Group leader
Maria Rosa Dalmau Llorca
rdalmau.ebre.ics@gencat.cat
Presentation
Team
Publications
Projects
News
Presentation
Team
Publications
Projects
News
Projects
Group projects
Nou circuit assitencial a AP pel pacient cronic. EBRECRONICS
Principal investigators:
Array
Code:
9F-0-00003-21
Start year:
Algoritme de suport a la Fibril·lació Auricular per prevenir l’Ictus “AFAI”
Principal investigators:
Maria Rosa Dalmau Llorca
Code:
4RC-0-00078-23
Start year:
2023
Funders:
Generalitat Catalunya
Asociación entre el tratamiento Asociación entre el tratamiento antiagregante o anticoagulante y la incidencia de ictus isquémicos en pacientes con fibrilación auricular en Cataluña.
Principal investigators:
Maria Rosa Dalmau Llorca
Code:
4RNC-0-00045-24
Start year:
2024
Xarelto Paediatric VTE PASS Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug use patterns and safety of rivaroxaban oral suspension in children under two years with venous thromboembolism (XAPAEDUS)
Principal investigators:
Maria Rosa Dalmau Llorca
Code:
4RNC-0-00090-24
Start year:
2024
Funders:
Bayer AG
Nuevo abordaje de la violencia machista en atención primaria basado en un algoritmo de inteligencia artificial y formación al profesional, con un proceso participativo: Proyecto VIOLETA
Principal investigators:
José Fernández Sáez, Carina Aguilar Martín
Code:
4RC-0-00036-24
Start year:
2025
Funders:
Instituto de Salud Carlos III
Anterior
1
2
3
4
5
…
8
Següent
Board of Trustees
Collaborators
Accreditations